* BioLineRx (NASDAQ:BLRX [https://seekingalpha.com/symbol/BLRX]) is scheduled to announce Q2 earnings results on Thursday, August 14th, before market open.
* The consensus EPS Estimate is -$0.53 [https://seekingalpha.com/symbol/BLRX/earnings/estimates] and the consensus Revenue Estimate is $0.66M (-87.8% Y/Y).
* Over the last 2 years, BLRX has beaten EPS estimates [https://seekingalpha.com/symbol/BLRX/earnings/eps-surprise-summary] 38% of the time and has beaten revenue estimates 38% of the time.
* Over the last 3 months, EPS estimates have seen 1 upward revision [https://seekingalpha.com/symbol/BLRX/earnings/revisions] and 0 downward. Revenue estimates have seen 0 upward revisions and 1 downward.
MORE ON BIOLINERX
* BioLineRx projects cash runway into H2 2026 while advancing PDAC pipeline and APHEXDA royalty growth [https://seekingalpha.com/news/4452832-biolinerx-projects-cash-runway-into-h2-2026-while-advancing-pdac-pipeline-and-aphexda-royalty]
* Seeking Alpha’s Quant Rating on BioLineRx [https://seekingalpha.com/symbol/BLRX/ratings/quant-ratings]
* Historical earnings data for BioLineRx [https://seekingalpha.com/symbol/BLRX/earnings]
* Financial information for BioLineRx [https://seekingalpha.com/symbol/BLRX/income-statement]
BioLineRx Q2 2025 Earnings Preview
Published 2 months ago
Aug 13, 2025 at 2:22 PM
Positive
Auto